5.4.20

Podcast 85: An Open Conversation About Insulin With Novo Nordisk | Dr. Todd Hobbs & Ken Inchausti

After a recent announcement from Novo Nordisk I cleared my schedule to record this episode with Dr. Todd Hobbs, Chief Medical Officer for North America and Ken Inchausti, Senior Director of Corporate Communications. In this open discussion they share resources and cost saving programs, details about insulin production, insulin trials and what’s on the horizon for insulin therapies. I learned SO much about a drug I’ve been taking for decades!

Thank you everyone for submitting your questions for this episode. Please feel free to contact me any time if there is someone you would like me to interview.

WATCH ON YOUTUBE:

SHOW NOTES:

  • Novocare.com
  • Hotline: 844.NOVO4ME  (M-F, 8:30am-11:00pm, Sat, 11:00am-7:00pm)

Programs:

Amber Clour was born and raised in Norman, Oklahoma. 21 days after her eighth birthday, she was rushed to Children’s Hospital where she spent two weeks learning how to live life with Type 1 diabetes. She has embraced the thought of being a #walkingscienceproject and hopes to score an A+ for her efforts to maintain a stable BG while living life to the fullest - whatever that means.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.